SolventumMIL:1SOLV 23 EBITDA Margin % is 10.62% as of Mar. 2026, which is 62% below its 10-year median of 27.90. GuruFocus rates MIL:1SOLV with a GF Score™ of 23/100. The stock has 8 warning signs investors should review. Among 816 Medical Devices & Instruments companies, Solventum ranks better than 90.81% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Solventum's EBITDA for the
three
months ended in Mar. 2026 was €184 Mil. Solventum's Revenue for the
three
months ended in Mar. 2026 was €1,735 Mil. Therefore, Solventum's EBITDA margin for the quarter that ended in Mar. 2026 was 10.62%.
Solventum (MIL:1SOLV) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Solventum EBITDA Margin % Related Terms
Solventum EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Solventum's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MIL:1SOLV vs ALGN, COO, BAX: EBITDA Margin % Comparison
For the Medical Instruments & Supplies subindustry, Solventum's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Solventum EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Solventum's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Solventum's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Solventum (MIL:1SOLV) has a EBITDA Margin % of 10.62% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Solventum and its competitors. This is 62% below median its historical median of 27.90. Over the past decade, Solventum's EBITDA Margin % has ranged from 18.50 to 30.62. According to the industry distribution chart, Solventum ranks #75 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 9.2%.
Is Solventum's EBITDA Margin % too high?
Solventum's current EBITDA Margin % of 10.62% is 62% below median its 10-year median of 27.90. Over the past 10 years, this metric has ranged from a low of 18.50 to a high of 30.62. The Medical Devices & Instruments industry median EBITDA Margin % is 7.48. Solventum's value of 10.62% is 42.1% above this industry median. Based on the distribution chart, Solventum ranks #75 out of 816 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Solventum has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Solventum's EBITDA Margin % compare to ALGN and COO?
According to the Medical Devices & Instruments industry distribution chart, Solventum ranks #75 out of 816 companies for EBITDA Margin %. This places Solventum in the top 9% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 7.48. Solventum's value of 10.62% is 42.1% above this benchmark. Historically, Solventum's own EBITDA Margin % has ranged from 18.50 to 30.62 over the past decade. While the company's 10-year median is 27.90 vs. the industry median of 7.48, Solventum has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.48, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Solventum's current EBITDA Margin % of 10.62% is 42.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Solventum and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Solventum's current EBITDA Margin % is 10.62%, which is 62% below median its own 10-year median of 27.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Solventum stock overvalued right now?
Solventum (MIL:1SOLV) has a current EBITDA Margin % of 10.62%. The current EBITDA Margin % is 10.62%, which is 62% below median its 10-year median of 27.90 and 42.1% above the Medical Devices & Instruments industry median of 7.48. Solventum's overall GF Score™ is 23/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Solventum (MIL:1SOLV), the current EBITDA Margin % is 10.62% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Solventum Corp is a healthcare company developing, manufacturing, and commercializing solutions leveraging material science, data science, and digital capabilities to address customer and patient needs. Its segments include MedSurg, which earns maximum revenue and provides wound therapy, I.V. site management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and OEM medical technologies; Dental Solutions, offering dental and orthodontic products such as brackets, restorative cements, and bonding agents; and Health Information Systems, providing software solutions including physician documentation, coding automation, speech recognition, and data visualization platforms. It operates in the United States, which earns the majority of revenue, and internationally.
23GF Score
Get the complete analysis for MIL:1SOLV
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIL:1SOLV has been successfully added to your 
